Abstract
Correction to: Oncogene, published online 7 January 2023 In this article the affiliation details for Author J. Gligorov were incorrectly given as 7,8,9,10,11,12,13,14, but should have been ‘7, 14’ and for Author J. Y. Pierga were incorrectly given as 1,2,3,4,5,6,7,8,9,10,11,12,13 but should have been 1, 13. In the abstract, the word “data” in the second sentence was misspelled “datda” The original article has been corrected.
Cite
CITATION STYLE
Bello Roufai, D., Gonçalves, A., De La Motte Rouge, T., Akla, S., Blonz, C., Grenier, J., … Lerebours, F. (2023, April 21). Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program (Oncogene, (2023), 10.1038/s41388-022-02585-3). Oncogene. Springer Nature. https://doi.org/10.1038/s41388-023-02615-8
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
